Search

Your search keyword '"Peter Wijngaard"' showing total 23 results

Search Constraints

Start Over You searched for: Author "Peter Wijngaard" Remove constraint Author: "Peter Wijngaard" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
23 results on '"Peter Wijngaard"'

Search Results

1. An evaluation of a supratherapeutic dose of inclisiran on cardiac repolarization in healthy volunteers: A phase I, randomized study

2. Pharmacokinetics and pharmacodynamics of inclisiran, a small interfering RNA therapy, in patients with hepatic impairment

3. Incidence, predictors, and outcomes associated with acute kidney injury in patients undergoing transcatheter aortic valve replacement: from the BRAVO-3 randomized trial

4. 459 Evaluation of LDL-C reductions by siRNA treatment with inclisiran in patients with diabetes mellitus, metabolic syndrome or neither

5. Pooled Patient-Level Analysis of Inclisiran Trials in Patients With Familial Hypercholesterolemia or Atherosclerosis

6. Abstract 16311: Efficacy and Safety of Inclisiran According to Sex: A Pooled Analysis of the ORION 9, 10 and 11 Trials

7. Abstract 16427: Efficacy and Safety of Inclisiran According to Age: A Pooled Analysis of Phase III Studies (ORION 9, 10 and 11)

8. Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial

9. Incidence, predictors, and outcomes associated with acute kidney injury in patients undergoing transcatheter aortic valve replacement: from the BRAVO-3 randomized trial

10. Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO-3 randomized trial

11. EVALUATION OF LDL-C REDUCTIONS BY SIRNA TREATMENT WITH INCLISIRAN IN PATIENTS WITH DIABETES MELLITUS, METABOLIC SYNDROME OR NEITHER

12. EFFECT OF INCLISIRAN ON LDL-C REDUCTION ACROSS DIFFERENT BACKGROUND LIPID LOWERING TREATMENTS: ANALYSES FROM ORION-11

13. INCLISIRAN AND CARDIOVASCULAR OUTCOMES: ANALYSES FROM ORION-11

14. Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement

15. Electrocardiographic Safety of Cangrelor, a New Intravenous Antiplatelet Agent

16. Projects without Email, Is that Possible?

17. Cyclosporine Withdrawal from a Mycophenolate Mofetil–Containing Immunosuppressive Regimen

18. Mycophenolate Mofetil Substitution for Cyclosporine A in Renal Transplant Recipients with Chronic Progressive Allograft Dysfunction: The ???Creeping Creatinine??? Study1

19. Cyclosporine withdrawal from a mycophenolate mofetil???containing immunosuppressive regimen in stable kidney transplant recipients: a randomized, controlled study1,2

20. INCIDENCE OF ACUTE KIDNEY INJURY WITH BIVALIRUDIN OR UNFRACTIONATED HEPARIN FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT: RESULTS FROM THE BRAVO-3 RANDOMIZED TRIAL

21. Mycophenolate mofetil substitution for cyclosporine a in renal transplant recipients with chronic progressive allograft dysfunction: the 'creeping creatinine' study

22. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen in stable kidney transplant recipients: a randomized, controlled study

23. Mycophenolate Sodium Does Not Reduce the Incidence of GI Adverse Events Compared with Mycophenolate Mofetil

Catalog

Books, media, physical & digital resources